A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899.
about
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer.Retinoids and rexinoids in cancer prevention: from laboratory to clinic.Putrescine treatment reverses α-tocopherol-induced desynchronization of polyamine and retinoid metabolism during rat liver regeneration.Low dose of interferon-α improves the clinical outcomes of docetaxel in patients with castration-resistant prostate cancer: A pilot studyAntimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer.Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation.
P2860
Q36421822-3F793E08-20EE-4D19-852C-7D279C91CD05Q36680198-F2880C22-BD18-4059-A8D4-77EE7D06A5A5Q37367394-38DA86C2-FAFE-46B7-B3A5-FD6A17CA2D35Q37388624-7BCE2748-DA98-46C7-88CF-40AD914BC511Q38099046-FF2E44AE-252D-49EF-8BF5-9A546B1200FDQ42378527-6F43CFD6-072B-4560-9C7E-E9E4C0E1E0ABQ48182143-2D64A1A3-21E8-49F3-AC2A-932082104F88
P2860
A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A randomized phase II trial of ...... nt prostate cancer: ECOG 3899.
@en
A randomized phase II trial of ...... nt prostate cancer: ECOG 3899.
@nl
type
label
A randomized phase II trial of ...... nt prostate cancer: ECOG 3899.
@en
A randomized phase II trial of ...... nt prostate cancer: ECOG 3899.
@nl
prefLabel
A randomized phase II trial of ...... nt prostate cancer: ECOG 3899.
@en
A randomized phase II trial of ...... nt prostate cancer: ECOG 3899.
@nl
P2093
P2860
P356
P1476
A randomized phase II trial of ...... nt prostate cancer: ECOG 3899.
@en
P2093
Bruce Roth
David Vaughn
Linda Patrick-Miller
Mark Stein
Michael Carducci
Robert S DiPaola
Yu-Hui Chen
P2860
P2888
P356
10.1186/1479-5876-8-20
P577
2010-02-24T00:00:00Z
P5875
P6179
1038783714